Pfizer Masterclass at CQIB Strategic Partnerships with Pharmaceutical Companies in Life
- Bradim Safar-Remali
- Feb 12
- 2 min read
Sciences Session delivered in English only
The CQIB is proud to welcome Pfizer for an exclusive masterclass designed for life sciences startups and growing companies looking to build meaningful partnerships with pharmaceutical leaders.
Collaborating with Big Pharma can dramatically accelerate your development, validation, and commercialization. But success depends on understanding how pharmaceutical companies evaluate opportunities, structure collaborations, and choose their partners.
Through practical insights, real case examples, and actionable strategies, this session will walk you through the full partnership journey — from the first pitch to long-term, high-impact collaborations.
What you’ll learn ?
Module 1 – Making the Right First Impression How pharma evaluates companies, key selection criteria, risk tolerance, and how to craft a compelling pitch.
Module 2 – Building a Strong CollaborationAligning objectives, managing communication, and leveraging pharma’s expertise, networks, and resources.
Module 3 – From Deal to Growth Licensing, co-development, joint ventures, commercialization partnerships, and scaling globally.
Who should attend ?
Life sciences founders, executives, startups, and business development professionals seeking to initiate or strengthen partnerships with pharmaceutical companies.
About the speaker – Shaan C. Gandhi
Vice President and Head of Partnerships for PAVE at Pfizer, Shaan leads strategic collaborations that expand Pfizer’s commercial portfolio through innovative operational and financial structures.
He previously headed Strategic Partnerships for Pfizer Ignite and held leadership and investment roles at Northpond Ventures and the Longwood Fund, where he co-founded Pyxis Oncology (NASDAQ: PYXS).
A former physician at Massachusetts General Hospital, Shaan holds an MD (Harvard Medical School), MBA (Harvard Business School – Baker Scholar), DPhil in Medical Oncology (Oxford – Rhodes Scholar), and a BS in Biochemistry.
Limited seats available – registration required.
Comments